CRLF1 Is a Key Regulator in the Ligamentum Flavum Hypertrophy
Zhenyu Zheng1,2, Xiang Ao1,2, Peng Li1,2
1Department of Orthopedics, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
Insights
The study identifies Cytokine Receptor Like Factor 1 (CRLF1) as a key driver of ligamentum flavum hypertrophy, a cause of lumbar spinal stenosis. Inhibiting CRLF1 may offer a new treatment for this condition.
Area of Science:
- Biomedical research
- Molecular biology
- Orthopedics
Background:
- Ligamentum flavum hypertrophy (HLF) is a common cause of lumbar spinal stenosis (LSS).
- The molecular mechanisms underlying HLF are not fully understood.
- Identifying key molecules involved in HLF is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the molecular mechanisms and key molecules involved in ligamentum flavum hypertrophy (HLF).
- To explore the role of Cytokine Receptor Like Factor 1 (CRLF1) in the development of HLF.
- To evaluate the potential of CRLF1 as a therapeutic target for HLF.
Main Methods:
- Integrated transcriptome and proteomics analysis of human ligamentum flavum (LF).
- Immunohistochemistry and real-time PCR assays to validate gene expression.
- In vitro and in vivo experiments using cell cultures and mouse models, including bipedal standing posture.
Main Results:
- CRLF1 is significantly upregulated in HLF and is a dominant molecular response.
- TGF-β1 signaling pathway, via SMAD3, upregulates CRLF1 mRNA expression.
- CRLF1 promotes LF fibrosis through the ERK signaling pathway and is essential for TGF-β1's pro-fibrotic effects.
- CRLF1 knockdown reduces fibrosis induced by inflammatory cytokines and mechanical stress.
- Bipedal standing posture induces HLF and CRLF1 upregulation in mice.
- CRLF1 overexpression causes HLF in vivo, while knockdown prevents HLF formation in bipedal standing mice.
Conclusions:
- CRLF1 plays a critical role in the pathogenesis of ligamentum flavum hypertrophy.
- CRLF1 mediates LF fibrosis and is implicated in HLF development under mechanical stress.
- Inhibition of CRLF1 represents a promising therapeutic strategy for treating lumbar spinal stenosis caused by HLF.
Abstract:
Hypertrophy of the ligamentum flavum (HLF) is one of the common causes of lumbar spinal stenosis (LSS). The key molecules and mechanisms responsible for HLF remain unclear. Here, we used an integrated transcriptome and proteomics analysis of human ligamentum flavum (LF), and subsequent immunohistochemistry and real-time PCR assays, to show upregulation of CRLF1 to be the dominant response to HLF. TGF-β1 significantly increased mRNA expression of CRLF1 through SMAD3 pathway. CRLF1 enhanced LF fibrosis via ERK signaling pathway at the post-transcriptional level and was required for the pro-fibrotic effect of TGF-β1. Knockdown of CRLF1 was shown here to reduce fibrosis caused by inflammatory cytokines and mechanical stress. Furthermore, we found that bipedal standing posture can cause HLF and upregulation of CRLF1 expression in mice LF. Overexpression of CRLF1 was indicated to cause HLF in vivo, whereas CRLF1 knockdown impeded the formation of HLF in bipedal standing mice. These results revealed a crucial role of CRLF1 in LF hypertrophy. We propose that inhibition of CRLF1 is a potential therapeutic strategy to treat HLF.
More Related Videos
06:51Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart
Published on: August 10, 2018
08:54Monitoring Leucine-Rich Repeat Containing 8 Channel (LRRC8/VRAC) Activity Using Sensitized-Emission Förster Resonance Energy Transfer (SE-FRET)
Published on: August 9, 2024
